AMD’s August 13, 2026 pricing term sheet fixes four senior unsecured note tranches at $4.75 billion of aggregate principal, with settlement expected on August 17. The term sheet establishes face amounts, coupons, maturities, yields and public offering prices. It does not establish that the notes have settled, how much cash AMD received after underwriting deductions and issuer expenses, or whether AMD repaid any existing debt.
That distinction changes the controller’s evidence sequence. Reuters reported the launch-stage range at $4 billion to $5 billion before pricing. The final principal is now $4.75 billion, while the public offering prices imply $4.7441875 billion before accrued interest, underwriting discounts and issuer-paid costs. That calculated amount is not net proceeds or verified bank cash. Until the closing pack is complete, the supportable status is priced and awaiting settlement.
What changed and what it means
Collapsing face principal, offering-price discount, issuance costs, settlement cash and any debt repayment can misstate debt carrying value, cash, financing cash flows and interest expense.
- Decision affected
- Post the funded position only after the settlement pack reconciles each tranche’s face principal, offering-price difference, issuance costs, cash receipt and any debt repayment.
- Evidence in brief
- AMD’s August 13 pricing term sheet fixes four senior-note tranches totaling $4.75bn, their public offering prices, coupons, maturities and an expected August 17 settlement.
- What remains unresolved
- The reviewed record does not establish actual settlement cash, underwriting deductions, issuer-paid expenses or any completed repayment of existing debt.
- Next verification
- On August 17, reconcile the closing memorandum, underwriter statement, bank receipt, debt documents and approved cost schedule before posting the funded position.
Key takeaways
- AMD priced $4.75 billion across four note tranches on August 13, with settlement expected on August 17, 2026.
- The filed public offering prices imply $4.7441875 billion before accrued interest, underwriting discounts and issuer expenses, not final net proceeds.
- Controllers should keep face principal, offering-price discount, issuance costs, settlement cash and any debt repayment in separate reconciled fields.
- The four coupons total $240 million a year, but effective interest requires the actual initial carrying amount and settlement evidence for each tranche.
What AMD priced and what remains unsettled
The pricing term sheet identifies an August 13 trade date and an August 17 T+2 settlement date, and fixes the coupons and public offering prices. AMD’s preliminary prospectus supplement, filed earlier that day, left principal amounts, coupons, offering prices, underwriting discounts and proceeds blank.
The file should preserve two states. The launch materials support preparation, but not the funded entry. The pricing term sheet supports the tranche master and initial calculations, but not final cash, eligible issuance costs or a repayment. AMD’s current filings page shows no later closing evidence in the record checked for this article.
Build the four-tranche source-of-truth schedule
Each series needs its own subledger, interest schedule, maturity record and carrying-value roll-forward. The $4.75 billion total should not replace the tranche detail.
| Tranche | Face principal | Public offering price | Calculated price × principal | Face-to-price difference | Annual cash coupon |
|---|---|---|---|---|---|
| 4.600% due 2029 | $1.250bn | 99.889% | $1.2486125bn | $1.3875m | $57.5m |
| 5.000% due 2031 | $1.500bn | 99.921% | $1.4988150bn | $1.1850m | $75.0m |
| 5.250% due 2033 | $1.000bn | 99.919% | $0.9991900bn | $0.8100m | $52.5m |
| 5.500% due 2036 | $1.000bn | 99.757% | $0.9975700bn | $2.4300m | $55.0m |
| Total | $4.750bn | Not applicable | $4.7441875bn | $5.8125m | $240.0m |
The calculated price amount is an intermediate control, not cash. The closing statement must establish any accrued-interest line and the deductions between investor consideration and issuer cash.
Separate face principal, offering-price discount and issuance costs
The $5.8125 million face-to-price difference comes directly from the filed principal and public offering prices. It should be retained separately from underwriting compensation, legal fees, rating-agency costs, trustee charges and other offering expenses. Those amounts are not disclosed in the pricing term sheet, and the preliminary prospectus leaves the underwriting and proceeds table blank.
FASB Accounting Standards Update 2015-03 requires debt issuance costs related to a recognized debt liability to be presented as a direct deduction from that liability’s carrying amount. The company still needs invoice-level evidence and its accounting policy to decide which costs qualify and how they are allocated across the four series.
Reconcile settlement cash before posting the funded position
The recognition pack should bridge investor consideration to bank cash by tranche and in total. The controller needs the closing memorandum, executed debt documents, underwriter settlement statement, bank receipt, trustee confirmation, approved cost schedule and debt-subledger setup.
The reconciliation starts with $4.7441875 billion, adjusts for any evidenced accrued interest, subtracts underwriting deductions and issuer-paid costs as applicable, and ties to cash received. It should also capture costs paid directly by underwriters or other parties.
Keep any repayment of the 2026 notes in a separate bridge
AMD said the proceeds may be used for general corporate purposes, including debt repayment. That wording does not identify a repayment, amount or execution date. AMD’s June 27, 2026 Form 10-Q reported $3.250 billion of debt principal, $24 million of unamortized discount and issuance costs, and a $3.226 billion net carrying amount. The current portion included $875 million of 4.212% notes due in 2026.
If AMD repays those notes, the close file should use a separate use-of-proceeds and derecognition bridge covering principal, accrued interest, any redemption amount, remaining unamortized discount and costs, cash classification and evidence date. The new issuance should not be netted against the old debt merely because the cash flows occur near each other.
Set coupon and effective-interest controls by tranche
The stated coupons produce $240 million of annual contractual cash interest and $120 million for a full semiannual period. That is a cash-payment schedule, not automatically the interest-expense schedule. The effective-interest calculation must begin with each tranche’s supported initial carrying amount after the accounting treatment of the price difference and qualifying issuance costs.
The first close control should confirm the actual issue date, day-count convention, accrual start, payment dates and allocation of costs. It should recalculate cash interest, effective interest and amortization independently, then tie the four schedules to the general ledger, debt roll-forward and disclosure table. Any difference between the expected August 17 settlement and the actual closing date must flow through the schedule rather than remain as a narrative note.
What the August 17 evidence must confirm
- the offering settled and the legal issue date for each series;
- the final investor consideration, accrued interest if any, underwriting deductions and issuer-paid expenses;
- the cash received and any payments made outside AMD’s bank account;
- the allocation of eligible issuance costs and the opening carrying amount by tranche;
- whether any existing debt was repaid, and the separate accounting for that event;
- the coupon, effective-interest and amortization schedules approved for the next close; and
- the tie among the closing documents, debt subledger, general ledger, cash flow statement and financial-statement disclosures.
Until those records are available, the controller can complete the priced-term schedule and prepare the posting template. The funded entry, final carrying values, repayment accounting and first-period interest should remain tied to the settlement evidence rather than inferred from the headline principal amount.
